momentum for biopharm comes.

(1) DNA and GENZ got bought. money needs to go somewhere.

(2) rhis sector has deep pocket and has been depressed for decade.

(3) first prostate cancer in innovative way by DNDN

(4) first MS drug approved for HGSI

(5) first melanoma drug is just approved for BMY.

(6) dead meat PFE even has a nice run recently.